Jonas Santol

6PUBLICATIONS
51CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 06, 2026
Intrahepatic Tissue-Resident CD8+ T-Cell Programmes Associate With Fibrosis and Local Immune Remodelling in Autoimmune Hepatitis.

|Jun 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart disease.

|Apr 28, 2025
PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis.

Sheue-Fen Tzeng, Yi-Ru Yu, Jaeoh Park

|Mar 13, 2024
Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial.

Yawen Dong, Jonas Santol, Birgit Gruenberger

|Jun 10, 2023
The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer.

Rebecca Thonhauser, Marcus Poglitsch, Jan Philipp Jonas

|Oct 05, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study.

David Pereyra, Stefan Heber, Waltraud C Schrottmaier

Pageof 1

Frequent Collaborators

3 joint publications

Patrick Starlinger

1 joint publications

David Pereyra

1 joint publications

Stefan Heber

1 joint publications

Waltraud C Schrottmaier